Back to Markets

AMGN vs JNJ

A side-by-side look at AMGN and JNJ, updated throughout the trading session.

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…
Live figures are refreshing. Check back in a moment.

AMGN vs JNJ: how they differ

Amgen Inc. (AMGN) and Johnson & Johnson (JNJ) are both in the Healthcare sector, in the same Drug Manufacturers - General industry. AMGN trades on NASDAQ and JNJ on NYSE.

AMGN trades about 2.7 million shares a day on average, against 7.6 million for JNJ. AMGN has the higher beta (0.41 against 0.23 for JNJ), meaning it has historically moved more with the broad market. Over the trailing twelve months, AMGN paid $9.94 per share in dividends and JNJ paid $5.28 per share.

Figures as of October 25, 2026.

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.